Try our Advanced Search for more refined results
Impax Laboratories, Inc. v. Turing Pharmaceuticals AG
Case Number:
1:16-cv-03241
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 15, 2016
NY Judge Looks To Trim Impax AIDS Drug Suit Against Turing
A Manhattan federal judge said Friday he is inclined to cut a claim of unjust enrichment from Impax Laboratories' $30 million breach of contract case against Turing Pharmaceuticals, whose ex-leader Martin Shkreli jacked up the price of AIDS drug Daraprim, as the companies tangle over higher Medicaid costs tied to the infamous price hike.
-
May 19, 2016
Judge Says Turing Concedes Liability In Impax AIDS Drug Row
A Manhattan federal judge declined Wednesday to block Turing Pharmaceuticals AG from selling AIDS drug Daraprim featuring the label of Impax Laboratories Inc. per a distribution contract but said Turing, whose ex-leader Martin Shkreli famously jacked up price of the drug, owes for higher Medicaid reimbursement costs tied to the price hike.
-
May 02, 2016
Impax Sues Ex-Shkreli Co. For $20M In Daraprim Dispute
Impax Laboratories Inc. in New York federal court on Monday sued Turing Pharmaceuticals AG, the drugmaker previously led by Martin Shkreli, for $20 million, saying that it flouted contractual terms after buying the rights to anti-parasite drug Daraprim and jacking up the product's price by 5,000 percent.